Macquarie Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-60,556
| Closed | -$5.91M | – | 1670 |
|
|
2015
Q1 | $5.91M | Buy |
60,556
+9,556
| +19% | +$932K | 0.01% | 695 |
|
|
2014
Q4 | $4.73M | Hold |
51,000
| – | – | 0.01% | 735 |
|
|
2014
Q3 | $3.51M | Buy |
51,000
+13,376
| +36% | +$920K | 0.01% | 815 |
|
|
2014
Q2 | $3.94M | Hold |
37,624
| – | – | 0.01% | 781 |
|
|
2014
Q1 | $3.12M | Sell |
37,624
-1,276
| -3% | -$106K | 0.01% | 851 |
|
|
2013
Q4 | $2.52M | Hold |
38,900
| – | – | ﹤0.01% | 900 |
|
|
2013
Q3 | $2.46M | Buy |
38,900
+8,829
| +29% | +$559K | ﹤0.01% | 854 |
|
|
2013
Q2 | $1.26M | Buy |
+30,071
| New | +$1.26M | ﹤0.01% | 1088 |
|